is l carnitine a blood thinner Carnitine: the claims and why it may not work L-Carnitine Benefits for Chronic Fatigue

These are discussed under the heads taxonomy, botany (including flowering behavior, dioecy, chemistry, functional properties, medicinal uses, and culinary uses

coli sepsis model The model of secondary HLH was performed using age-matched (8-week-old) female and male WT littermate control ( n = 8) and Ankib1 / ( n = 9) mice as described previously 78

Supplementary material The Supplementary Material for this article can be found online at: Glossary ACO acyl coenzyme A oxidase AMPK adenosine monophosphate-activated protein kinase ANCOVA analysis of covariance aP2 adipose-specific fatty acid-binding protein ARR absolute risk reduction BAT brown adipose tissue BMI body mass index BSH bile salt hydrolase CFU colony-forming unit Chol cholesterol ChREBP carbohydrate-responsive element-binding protein CI confidence interval CPT-Ia carnitine palmitoyltransferase Ia ELISA enzyme-linked immunosorbent assay FBG fasting blood glucose FBS fasting blood sugar FBP2 fructose-1,6-bisphosphatase isozyme 2 FFAs free fatty acids FFAR3 free fatty acid receptor 3 FFAR2 free fatty acid receptor 2 FIAF fasting-induced adipose factor FOS fructo-oligosaccharide FXR farnesoid X receptor GLP-1 glucagon-like peptide-1 GLP-2 glucagon-like peptide-2 GPR41 G protein-coupled receptor 41 GPR43 G protein-coupled receptor 43 GPCRs G protein-coupled receptors HC hip circumference HDL-C high-density lipoprotein-cholesterol HMG-CoA hydroxymethylglutaryl CoA reductase HOMA-IR homeostatic model assessment of insulin resistance HSL hormone-sensitive lipase IGF-1 insulin-like growth factor 1 IPAQ-SF International Physical Activity Questionnaire-Short Form ITT intention-to-treat LDL-C low-density lipoprotein-cholesterol LPL lipoprotein lipase LPS lipopolysaccharide METs metabolic equivalent of tasks NF-B nuclear factor kappa B NHLBI National Heart, Lung, and Blood Institute NNT number needed to treat NSAIDs non-steroidal anti-inflammatory drugs OTC over the counter PC percent of changes PCK1 phosphoenolpyruvate carboxykinase PDHC pyruvate dehydrogenase complex PPAR- peroxisome proliferator-activated receptor-gamma PGC-1 peroxisome proliferator-activated receptor-gamma coactivator 1 PYY peptide YY QUICKI quantitative insulin sensitivity check index RAS random allocation software RCT randomized clinical trial REE resting energy expenditure SCFAs short-chain fatty acids SD standard deviation SREBP sterol regulatory element-binding protein TC total cholesterol TG triglyceride TGR5 Takeda G protein-coupled bile acid receptor 5 TLR-LPS Toll-like receptor-LPS TLR4 Toll-like receptor 4 UCP-1 uncoupling protein-1 VLDL very low-density lipoprotein WAT white adipose tissue WC waist circumference WHR waist to hip ratio References 1 BleichSNCutlerDMurrayCAdamsA

doi: 10.1016/j.peptides.2007.03.006 45

10.1016/j.envint.2023.108048 227 MammolaS

European Journal of Clinical Investigation, 18 (5), 512516